Chromogranin A in Diagnosing and Monitoring Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Large Series from a Single Institution

Publisher： Karger

E-ISSN： 1423-0194|100|2-3|240-249

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.100, Iss.2-3, 2014-11, pp. : 240-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chromogranin A Is a Reliable Biomarker for Gastroenteropancreatic Neuroendocrine Tumors in an Asian Population of Patients

By  

Neuroendocrinology, Vol. 95, Iss. 4, 2012-02 ,pp. : 344-350

Karger

Access to resources Recommend Favorite

Therapeutic Monitoring of Gastroenteropancreatic Neuroendocrine Tumors: The Challenges Ahead

By  

Neuroendocrinology, Vol. 96, Iss. 4, 2012-10 ,pp. : 261-271

Karger

Access to resources Recommend Favorite

TNF-α Promoter Single Nucleotide Polymorphisms in Gastroenteropancreatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 84, Iss. 5, 2007-03 ,pp. : 346-352

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas

By  

Neuroendocrinology, Vol. 95, Iss. 2, 2011-12 ,pp. : 135-156

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Colorectal Neuroendocrine Neoplasms

By  

Neuroendocrinology, Vol. 95, Iss. 2, 2011-12 ,pp. : 88-97

Karger

Access to resources Recommend Favorite